CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Atossa Therapeutics founder to be selected as NIAID director — report

Positive
AI Analysis

Summary

Steven Quay, founder and CEO of clinical-stage biotech Atossa Therapeutics, is reportedly likely to be selected as the next director of the NIH's National Institute of Allergy and Infectious Diseases.

Importance:4/10
Sentiment:
0.30
leadershipregulatoryNIAIDNIHmanagement
Related Companies

Read the original article

Published by Endpoints News on August 5, 2026 6:16 PM

Read Original